BridgeBio Pharma, Inc. (NASDAQ:BBIO) Q3 2025 Earnings Call Transcript October 29, 2025
BridgeBio Pharma, Inc. misses on earnings expectations. Reported EPS is $-0.95 EPS, expectations were $-0.88.
Operator: Good afternoon. I will be your conference operator today. [Operator Instructions] Before we begin, I would like to remind everyone that today’s call may contain forward-looking statements within the meaning of the federal securities laws, including, but not limited to, statements about...
